GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
O

Onconetix ONCO · USD

Health Care · US listing · 🇺🇸 United States

Compare

3.58

-48.49%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Onconetix

Our reporting

We have not reported on Onconetix yet.

Next results

12 Nov 2026

Due on 12 Nov 2026. Analysts expect earnings of -45050.00 a share on revenue of $17,455.

Past results

Reported against what analysts expected

13 Aug 202613 May 202612 Mar 202613 Nov 202514 Aug 202512 Jun 2025
Earnings per share-1.28-6.7112.58-31.25-2.0210.59
Forecast-4505.00———-204.00-348.50
Revenue$17,120$21,457$303,596$303,651$106,494$101,630
Forecast$17,120—————

Key events

  1. 6 Nov 202610-to-1 reverse split
  2. 21 May 202610-to-1 reverse split
  3. 25 Mar 20265-to-1 reverse split
  4. 13 Jun 202585-to-1 reverse split
  5. 24 Sept 202440-to-1 reverse split
  6. 18 Feb 2022Listed

Onconetix in the news

Headlines from other publishers, linked to their own pages.

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.